Price level: $0.6454 is essentially at/just under S1 (0.647). A clean reclaim back above 0.647–0.764 (pivot) is needed to improve the setup.
MACD: Histogram at +0.0108 (above zero) but positively contracting → bullish momentum is weakening, not strengthening.
RSI(6): 34.3 (weak/near-oversold zone but not a clear reversal trigger on its own).
Key levels: Support S1 0.647 then S2 0.575; Resistance pivot 0.764 then R1 0.88 and R2 0.952.
Pattern-based forward bias: model suggests slightly negative near-term (-0.36% next day, -0.43% next week) with a higher-volatility upside possibility over a month (+19.71%), implying chop/mean-reversion potential but not a clean current entry.
Positive Catalysts
on 2026-01-05, citing merger/acquisition integration and licensing potential.
was strong YoY (+147.78%), which can help the story if margins stabilize.
Neutral/Negative Catalysts
Multiple recent items flag the stock (and peers) as among the lowest-rated / caution-advised names, which can suppress demand and sentiment.
Technical setup is bearish with price sitting at/under support and below major moving averages.
Fundamentals show profitability/margin deterioration in the latest quarter: gross margin collapsed and losses deepened (details below).
No supportive “smart money” signals: hedge fund and insider trends are neutral; no congress trading data to reinforce conviction.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $2.904M, +147.78% YoY (strong top-line growth off a small base).
Net income: - $32.976M (reported as “increased” YoY, which implies the loss widened materially).
EPS: -0.33, down -76.26% YoY (worse per-share performance).
Gross margin: 3.27%, down -83.04% YoY (major deterioration; this is a key negative because it undermines operating leverage even with revenue growth).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: One notable update (2026-01-05) with Maxim raising price target to $4 from $3 and maintaining a Buy.
Wall Street “pros” view (from the provided data):
Pros: Belief in improved strategic positioning post-merger/acquisition and licensing/IP monetization upside.
Cons: Current market/quant-style sentiment is negative and the company’s latest reported profitability and margin profile is weak, making the bullish PT highly execution-dependent.
Net takeaway: Despite the bullish analyst note, the tape + fundamentals in the latest quarter do not support treating DVLT as a buy right now.
Wall Street analysts forecast DVLT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVLT is 4 USD with a low forecast of 4 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast DVLT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DVLT is 4 USD with a low forecast of 4 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.640
Low
4
Averages
4
High
4
Current: 0.640
Low
4
Averages
4
High
4
Maxim
NULL -> Buy
maintain
$3 -> $4
AI Analysis
2026-01-05
Reason
Maxim
Price Target
$3 -> $4
AI Analysis
2026-01-05
maintain
NULL -> Buy
Reason
Maxim raised the firm's price target on Datavault to $4 from $3 and keeps a Buy rating on the shares. Following the WiSA merger and the strategic acquisition of CSI, along with new licensing deals and a $150M Bitcoin infusion from Scilex, the company's IP portfolio across Web 3.0, audio technologies, and data monetization is increasingly promising, the analyst tells investors in a research note.
Maxim
Maxim
Hold
to
Buy
upgrade
$3
2025-06-12
Reason
Maxim
Maxim
Price Target
$3
2025-06-12
upgrade
Hold
to
Buy
Reason
Maxim upgraded Datavault to Buy from Hold with a $3 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DVLT
